Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 7.31% is 46% above its 5-year average of 5.01%, near the high end of its 5-year range (-153.55%–12.24%).
8.63% below its 12-month average of 8.00%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 5.84%.
OPERATING MARGIN
7.31%
OPERATING MARGIN AVG TTM
8.00%
OPERATING MARGIN AVG 3Y
5.70%
OPERATING MARGIN AVG 5Y
5.01%
OPERATING MARGIN AVG 10Y
-0.79%
OPERATING MARGIN AVG 15Y
-3.89%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.63%
CURRENT VS 3Y AVG
+28.15%
CURRENT VS 5Y AVG
+45.81%
CURRENT VS 10Y AVG
+1020.76%
CURRENT VS 15Y AVG
+287.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$87.86M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$88.21M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
Market Cap
$84.75M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.70M
Operating Margin
29.69%
TTM Avg
-17.51%
3Y Avg
-923.94%
5Y Avg
-894.93%
Market Cap
$84.00M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$83.96M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$91.33M
Operating Margin
-37.64%
TTM Avg
-44.68%
3Y Avg
-118.22%
5Y Avg
-258.09%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareCloud, Inc. (CCLD) | $86.69M | 7.31% | 8.00% | 5.70% | 5.01% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 12.60% | -0.11% | -11.38% | -8.86% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 29.69% | -17.51% | -923.94% | -894.93% |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.33M | -37.64% | -44.68% | -118.22% | -258.09% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | -10.06% | -113.57% | -75.71% |
Gross Margin
46.5%
Operating Margin
7.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 5.84% |
| 2026-03-31 | 3.38% |
| 2025-12-31 | 9.51% |
| 2025-09-30 | 10.33% |
| 2025-06-30 | 10.94% |
| 2025-03-31 | 7.31% |
| 2024-12-31 | 12.24% |
| 2024-09-30 | 11.44% |
| 2024-06-30 | 8.08% |
| 2024-03-31 | 0.50% |
| 2023-12-31 | -153.55% |
| 2023-09-30 | -6.73% |
| 2023-06-30 | -4.39% |
| 2023-03-31 | -0.74% |
| 2022-12-31 | 2.93% |
| 2022-09-30 | 5.01% |
| 2022-06-30 | 7.40% |
| 2022-03-31 | 3.44% |
| 2021-12-31 | 10.39% |
| 2021-09-30 | 3.72% |
| 2021-06-30 | -0.31% |
| 2021-03-31 | -5.65% |
| 2020-12-31 | 1.29% |
| 2020-09-30 | -4.47% |
| 2020-06-30 | -23.55% |
| 2020-03-31 | -12.97% |
| 2019-12-31 | 5.48% |
| 2019-09-30 | 3.97% |
| 2019-06-30 | -7.33% |
| 2019-03-31 | -1.58% |
| 2018-12-31 | -5.26% |
| 2018-09-30 | -10.46% |
| 2018-06-30 | 0.83% |
| 2018-03-31 | 0.47% |
| 2017-12-31 | -5.48% |
| 2017-09-30 | -3.66% |
| 2017-06-30 | -17.77% |
| 2017-03-31 | -29.31% |
| 2016-12-31 | -42.54% |
| 2016-09-30 | -23.78% |
| 2016-06-30 | -20.53% |
| 2016-03-31 | -35.31% |
| 2015-12-31 | -9.55% |
| 2015-09-30 | -22.76% |
| 2015-06-30 | -25.17% |
| 2015-03-31 | -19.02% |
| 2014-12-31 | -7.10% |
| 2014-09-30 | -47.05% |
| 2014-06-30 | -14.88% |
| 2014-03-31 | -12.51% |
| 2013-12-31 | 8.62% |
| 2013-09-30 | -7.35% |
| 2013-06-30 | -6.85% |
| 2013-03-31 | 0.06% |
| 2012-12-31 | 1.53% |
| 2012-09-30 | 3.49% |
